Kristina Jansen

graph of relations

Publications

  1. 2023
  2. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer

    Weidemann, S., Gorbokon, N., Lennartz, M., Hube-Magg, C., Fraune, C., Bernreuther, C., Clauditz, T. S., Jacobsen, F., Jansen, K., Schmalfeldt, B., Wölber, L., Paluchowski, P., Berkes, E., Heilenkötter, U., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Simon, R., Krech, T., Marx, A., Burandt, E. & Lebok, P., 01.02.2023, In: APPL IMMUNOHISTO M M. 31, 2, p. 77-83 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2022
  4. DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer

    Jansen, K., Kluth, M., Blessin, N. C., Hube-Magg, C., Neipp, M., Mofid, H., Lárusson, H., Daniels, T., Isbert, C., Coerper, S., Ditterich, D., Rupprecht, H., Goetz, A., Bernreuther, C., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Perez, D., Izbicki, J. R., Jacobsen, F., Clauditz, T. S., Marx, A. H. & Krech, T., 08.2022, In: HISTOL HISTOPATHOL. 37, 8, p. 739-748 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2021
  6. Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness

    Weidemann, S., Perez, D., Izbicki, J. R., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Jacobsen, F., Bernreuther, C., Simon, R., Steurer, S., Burandt, E., Marx, A. H., Krech, T., Clauditz, T. S. & Jansen, K., 10.2021, In: CANCER INVEST. 39, 9, p. 711-720 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

    Weidemann, S., Gagelmann, P., Gorbokon, N., Lennartz, M., Menz, A., Luebke, A. M., Kluth, M., Hube-Magg, C., Blessin, N. C., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Clauditz, T. S., Jacobsen, F., Izbicki, J. R., Jansen, K., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Minner, S., Burandt, E., Krech, R. H., Dum, D., Krech, T., Marx, A. H. & Simon, R., 07.04.2021, In: BIOMEDICINES. 9, 4, 397.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness

    Jansen, K., Büscheck, F., Moeller, K., Kluth, M., Hube-Magg, C., Blessin, N. C., Perez, D., Izbicki, J., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Fraune, C., Jacobsen, F., Bernreuther, C., Lebok, P., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Marx, A., Krech, T. & Clauditz, T., 2021, In: PEERJ. 9, e11905.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2020
  10. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

    Bonk, S., Kluth, M., Jansen, K., Hube-Magg, C., Makrypidi-Fraune, G., Höflmayer, D., Weidemann, S., Möller, K., Uhlig, R., Büscheck, F., Luebke, A. M., Burandt, E., Clauditz, T. S., Steurer, S., Schlomm, T., Huland, H., Heinzer, H., Sauter, G., Simon, R. & Dum, D., 09.2020, In: PROSTATE. 80, 13, p. 1097-1107 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review